Novel target for reducing flare in giant cell arteritis
An investigational monoclonal antibody that inhibits GM-CSF receptor alpha shows promise, researchers say
AusDoc brings you the latest news from the American College of Rheumatology virtual congress 2020.
A new option for treating giant cell arteritis might be on the horizon, a conference has heard.